Wexford Capital’s Bausch Health BHC Stock Holding History

Wexford Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-77,500	Closed	-$1.99M	–	83
2018 Q3	$1.99M	Buy	+77,500	New	+$1.77M	0.13%	79
2014 Q4	–	Sell	-6,000	Closed	-$787K	–	60
2014 Q3	$787K	Sell	6,000 -97,650	-94%	-$11.6M	0.07%	88
2014 Q2	$13.1M	Buy	103,650 +23,327	+29%	+$2.98M	0.97%	11
2014 Q1	$10.6M	Buy	+80,323	New	+$11M	0.8%	12

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Wexford Capital's BHC Position: Q4 2018 in Review

Wexford Capital sold out of Bausch Health (BHC) in Q4 2018, closing a stake of 77,500 shares — an estimated $1.99M sold.

Wexford Capital first reported a position in BHC in Q1 2014 and held it in 4 quarters. The position peaked at $13.1M in Q2 2014. 334 funds tracked by Wall St. Rank hold BHC as of Q4 2018.

Wexford Capital reported no remaining Bausch Health position as of Q4 2018 after selling out during the quarter.
Wexford Capital sold 77,500 Bausch Health shares in Q4 2018, an estimated $1.99M.
Wexford Capital first reported a position in Bausch Health in Q1 2014 and held it in 4 quarters.
Wexford Capital's Bausch Health position peaked at $13.1M in Q2 2014.
334 funds tracked by Wall St. Rank held Bausch Health as of Q4 2018.

Based on Wexford Capital's 13F filing for Q4 2018, filed 14 Feb 2019.